Jump to Main Contents
ncc en

Home > Information > Press Release

Press Release

May 14, 2024
World’s Largest Whole Genome Sequencing of Renal Cancer:
mutational signature linked to an unknown exposure discovered in 70% of Japanese samples
May 8, 2024
Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure
Jan. 15, 2024
Result of a Japan-led International Investigator-Initiated Registration-Directed Trial Offers a New Treatment Option of Palbociclib in Combination with Tamoxifen
Jan. 12, 2024
Team explores role of STING – stimulator of interferon genes – in body’s innate immune system
Jan. 11, 2024
An Asian Multicenter Clinical Trial Evaluating Efficacy of
Computer-Aided Detection for Colonoscopy in Colorectal Cancer Screening
Dec. 14, 2023
National Cancer Center Japan and Japan Investment Corporation (JIC) sign agreement to promote comprehensive collaboration
Dec. 1, 2023
Sharing of clinical trial information improves the quality of treatment recommendations by expert panels
Nov. 29, 2023
Molecular Mechanisms of Chromosomal Instability and Anti-Tumor Immune Activation Induced by DNA Replication Stress
Sep. 20, 2023
Research agreement on CAR-T cancer treatment development concluded between National Cancer Center and Asahi Kasei
Aug. 14, 2023
Carcinogenesis mechanism of gastric cancer discovered with whole genome sequencing
Jun. 27, 2023
Memorandum of Cooperation on Decentralized Clinical Trials between the Department of Medical Services and the National Cancer Center Japan.
Jun. 12, 2023
Announcing the approval of the apolipoprotein A2 isoform index for in vitro diagnostics in Japan
Apr. 19, 2023
World-first confirmation of standard treatment for RAS wild-type colorectal cancer-Paper published in JAMA-
Apr. 12, 2023
Start of Clinical Research of the First Japanese-Produced Next-Generation Photon Counting Computed Tomography
Apr. 10, 2023
Efficacy of Anti-HER2 Therapy with Trastuzumab Deluxecan in Uterine Carcinosarcoma Consistent with PDX-model predictions of efficacy, paving the way for the development of treatments for rare cancers.
Apr. 3, 2023
A clinical trial of Tazemetostat for pediatric and AYA patients with malignant tumors which have no standard treatment or which is refractory to standard treatment using Patient-Proposed Healthcare Service (NCCH2214/ TURTLE trial) to improve drug access for pediatric and AYA patients with refractory tumors.
Mar. 14, 2023
World’s Largest Gastric Cancer Genomic Study Reveals Treatment Targets for Japanese Patients Alcohol intake link gives hope for improving prevention strategies
Feb. 28, 2023
Questionable practices identified by an examination of therapeutic plan reviews performed by certified committees under the Act on the Safety of Regenerative Medicine
Jan. 24, 2023
Clinical Utility of Circulating Tumor DNA After Surgery for Colorectal Cancer Demonstrated in a Large-Scale Prospective Study -A Step toward Personalized Postoperative Adjuvant Chemotherapy-
Jan. 5, 2023
Moonshot Research and Development Program ‘Actualization of a cancer-free society through regulation of chronic inflammation’ launched
Dec. 8, 2022
Asian multicenter prospective study (CHOICE study) to elucidate the pathogenesis of cholangiocarcinoma(including FGFR2-rearranged) launched
Nov. 4, 2022
Cancer Genomic Medicine in Japan Engages International Interest - Article Published on Cancer Discovery
Oct. 7, 2022
Fusion genes as drug resistance in EGFR mutant lung cancer
Sep. 27, 2022
Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform
Sep. 27, 2022
Study pinpoints origin of pediatric brain tumour and shows it may be preventable
Aug. 24, 2022
Large scale clinical trial for Neuroendocrine Carcinoma (NEC), a rare and refractory cancer establishes current chemotherapy for advanced and recurrent cancer as standard therapy
Aug. 5, 2022
Prospective Cohort Study demonstrates ESD as primary choice of treatment for neoplasia of over 2cm
Aug. 4, 2022
Approximately 43,000 individual patient data of clinical trials with colorectal cancer in Asia and the West shared
Aug. 1, 2022
First Japanese and Asian Chairperson of IARC Scientific Council
Dr. Manami Inoue, Chief – Institute for Cancer Control, NCC
Contributing to Global Cancer Control
Jul. 21, 2022
Joint Research with IARC Identifying associations between lifestyle risk factors and the prognosis of cancer survivors
Jul. 1, 2022
Utility of gene panel testing for comprehensive genomic profiling of blood cancers demonstrated
Mar. 3, 2022
Discovery of splicing vulnerability and novel therapy in RAS Q61 cancers -Nature-
Jan. 28, 2022
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Dec. 24, 2021
Depletion of central memory CD8+T cells might impede the antitumor therapeutic effect of Mogamulizumab
Dec. 23, 2021
Launch of an Asian international collaborative prospective study on 6 advanced cancers common in Asia
Dec. 21, 2021
CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,
identified using LC-SCRUM-Asia genomic screening platform
Nov. 15, 2021
Activated WNT/β-catenin pathway induces resistance to immunotherapies in cancers harboring high tumor mutation burden
Nov. 12, 2021
Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer
Nov. 11, 2021
First in-patient transplantation of iPS cell-derived natural killer cells to treat ovarian cancer
Oct. 28, 2021
Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma
Oct. 27, 2021
Global whole genome sequencing research on esophageal cancers reveals
carcinogenic mechanisms specific to Japan
Oct. 20, 2021
Oct. 14, 2021
Breakthrough Discovery on the Structure and Activation Mechanism of ALK
Sep. 6, 2021
Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
Aug. 17, 2021
Whole Genome Sequencing Finds Therapeutic Targets for Linitis Plastica-type Gastric Cancer
Jun. 30, 2021
Initiation of the 4th-stage industry-academia collaborative Cancer Genome Screening Project for Individualized Medicine in Japan, SCRUM-Japan
Jun. 2, 2021
SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
May 17, 2021
"MONSTAR-SCREEN" has joined as an official member program in the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO)
May 14, 2021
Apr. 27, 2021
National Cancer Center Japan and Pharmaceuticals and Medical Devices Agency Endorsed as a joint Center of Excellence by APEC
Mar. 23, 2021
First drug approved for unresectable thymic carcinoma
Feb. 2, 2021
Deep Vision: Near-Infrared Imaging and Machine Learning Can Identify Hidden Tumors
Oct. 6, 2020
Development of Precision Medicine for Gastrointestinal Cancers Utility of Liquid Biopsy in Genomic Analysis
Sep. 9, 2020
Asian early phase drug development network
ATLAS Project – Paving the way towards developing drugs with Asian partners
Sep. 1, 2020
A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies
Jul. 3, 2020
The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluate a SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
Jun. 22, 2020
National Cancer Center Japan and Mitsui Fudosan Agree on Accommodation Facility at the National Cancer Center Hospital East in Kashiwa-no-ha Smart City
Apr. 1, 2020
Advanced Medical Care Approval for Cancer Gene Panel Testing at the Time of Initial Treatment
- Prospective Study to Assess the Feasibility and Clinical Utility of Comprehensive Genomic Profiling at the Time of Initial Treatment of Patients with Solid Tumors -
Feb. 17, 2020
Global Consortium Completes Tumor Analyses Project
Dec. 11, 2019
Test Result of New Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting Proves Higher Efficacy Than Standard Antiemetic Therapy
May 29, 2019
Cancer Gene Panel Test OncoGuideTM NCC Oncopanel System added to Health Insurance Coverage list
Mar. 26, 2019
Launch a joint research project on a new cancer immunotherapy using liposome, a drug delivery system technology
-Goal is to identify its actions on immune cells, and elucidate the mechanism by which survival periods are extended-
Nov. 12, 2018
Facilitating International Clinical Trials Initiated by
Japanese Academic Institutions
Japan-led Global Investigator-Initiated Registration-Directed Trial of Advanced or Metastatic Breast Cancer (PATHWAY trial) Has Started
Oct. 1, 2018
National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
Jun. 27, 2018
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
Jun. 1, 2018
NCC Establishes Center for Cancer Genomics and Advanced
Therapeutics (C-CAT) to Aggregate and Manage Information on
Cancer Genomic Medicine and Promote Its Use
May 7, 2018
National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
Apr. 3, 2018
National Cancer Center Hospital offers Next Generation Sequencing tests as ‘Advanced Medical Care’
Towards coverage under national health insurance system
Apr. 3, 2018
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing
to Advancing Personalized Medicine
Mar. 13, 2018
SCRUM-Japan GI-SCREEN Aims for Realizing of Cancer Precision Medicine Utilizing Liquid Biopsy by Analyzing Comprehensive Cancer Genome Alterations in Blood
Feb. 14, 2018
A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects
Jan. 23, 2018
Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style
Dec. 22, 2017
T. Matsuda takes office of International Association of Cancer Registries President
Dec. 5, 2017
NCC signs comprehensive MoU with WHO/IARC
Nov. 27, 2017
Asian Early Phase Oncology Drug Development Consortium Formed
Oct. 27, 2017
Collaborative Research on Fully-personalized Cancer Neoantigen Vaccine
Oct. 16, 2017
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer Patients
Aug. 3, 2017
Japan-Singapore lead international research in discovering potential targeted treatments for biliary tract cancer
Jul. 31, 2017
Genomic medicine in Rare Cancers:
A collaboration between the industry and academia
Jun. 26, 2017
A novel biomarker for development of a new screening technique for early-stage pancreatic cancer and precancerous conditions associated with risk of pancreatic malignancy - experimental screening in Kagoshima Prefecture
May 30, 2017
WHO/International Agency for Research on Cancer establishes National Cancer Center as Global Initiative for Cancer Registry Development Collaborating Centre
Apr. 27, 2017
Elucidation of the mechanism of MLL-rearranged leukemia Use of two molecularly targeted drugs as novel therapy
Mar. 1, 2017
Commencement of Phase 1 Trial for the Mutant IDH1 Inhibitor (DS-1001)Targeting Malignant Brain Tumors
Feb. 28, 2017
Malignant extracellular vesicles derived from ovarian cancer cells facilitate peritoneal dissemination, and the vesicles can be promising targets for improving patient outcomes.
Feb. 21, 2017
Signing MOU with the National Cancer Research Institute (UK)
Jan. 1, 2017
Press Release:Joint R&D with the Goal of Commercialization of a Scaled-Down,Methylated DNA Detection Device for Renal Cell Carcinoma Prognostication,and Other Cancers,by 2018.
Jan. 1, 2017
Press Release:Signing MOU with the Institut National du Cancer (French National Cancer Institute)
Jan. 1, 2017
Press Release:National Cancer Center of Japan and Takeda Partner to Discover Anti-Cancer Agents
Jan. 1, 2017
Development of a Novel Nucleic Acid Drug Discovered by National Cancer Center
Dec. 21, 2016
New Risk Diagnosis Technique for Additional Gastric Cancer After Endoscopic Curative Treatment of A Gastric Cancer
Nov. 15, 2016
First National Project Using 8K Super Hi-Vision Technology for Medical Applications Start of Efforts toward the Practical Realization of a Laparoscopic Surgery System
Aug. 29, 2016
Discovery of a novel Wnt inhibitor with potential to eradicate colorectal cancer stem cells
Aug. 9, 2016
HLA-class II and other gene loci associated with susceptibility to EGFR-mutated lung adenocarcinoma
Aug. 5, 2016
New simple storage method for faecal samples offers improvements in the metagenomic analysis and the study of disease
Mar. 22, 2016
Commencement of First-in-Human Clinical Trial for New Molecular Targeting Drug,Co-Developed with The University of Tokyo and National Cancer Center,to Treat Malignant Lymphoma (Including Adult T-cell Leukemia-Lymphoma)
Nov. 13, 2015
Sysmex Opens Lab within the National Cancer Center to Promote the Development of New Cancer Diagnosis Methods
Nov. 13, 2015
TOP-GEAR Project Aiming to Realize Genome TreatmentGenetic Testing Lab Established within National Cancer Center HospitalIntroduction of Comprehensive Genetic Testing to Select Patient Treatments
Nov. 9, 2015
The development of a plasma biomarker for early detection of pancreatic cancer
Aug. 11, 2015
Large-scale genome sequencing of biliary tract cancer
Feb. 23, 2015
Press Release:New in vitro diagnostic product which can simultaneously detect multiple RAS gene mutations in colorectal cancer